Business Context and Reporting Period
This Form 8-K is a current report filed by Landec Corporation (not Lifecore Biomedical, Inc., as indicated in the metadata) on October 19, 2010, regarding events occurring on October 14, 2010. The filing details the results of the Company's Annual Meeting of Stockholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The Company held its Annual Meeting to vote on two proposals:
- Election of Directors: Four Class 1 directors were elected. All nominees received majority support, though significant votes were withheld for Frederick Frank and Richard S. Schneider, Ph.D.
- Ratification of Auditors: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending May 29, 2011.
| Proposal | Votes For | Votes Against/Withheld | Abstentions |
|---|---|---|---|
| Election of Directors (Total) | 63,819,013 | 13,149,779 | 17,125,556 (Broker Non-Votes) |
| Ratification of Ernst & Young LLP | 22,011,301 | 1,496,202 | 16,334 |
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Important Facts for Investors to Verify
- Verify the discrepancy between the metadata company name ("LIFECORE BIOMEDICAL, INC.") and the actual registrant in the filing ("LANDEC CORPORATION").
- Note the significant number of votes withheld for directors Frederick Frank and Richard S. Schneider, Ph.D., compared to the other nominees.
- Confirm the fiscal year end date of May 29, 2011, for future financial reporting expectations.